Given the pivotal position NRF2 occupies in chemoprevention and cancer therapy, the activation of the NRF2/KEAP1 signaling pathway in cancer cells often results in chemoresistance, neutralizing drug-induced oxidative stress, and shielding cancer cells from drug-mediated cell death (37). This evidence concerns the gene KEAP1 and cancer.